Sponsor
Quebec Consortium for Drug Discovery (CQDM)
Description
CQDM is searching for world-class research on RNA therapeutics and relevant modalities to present to domain experts from leading global pharmaceutical organizations on May 29, 2025.
The objective is to bring groundbreaking, innovative Canadian research to CQDM’s pharmaceutical members and facilitate interactions between their pharma members and the Canadian ecosystem. Collaborative projects developed with a CQDM pharmaceutical member are eligible to obtain funding via CQDM’s Quantum Leap program.
CQDM invites passionate Canadian researchers and visionary teams to submit innovative ideas that have the potential to transform the landscape of medicine and improve patient outcomes.
Please consult the full call notice (see attachments) for details about the focus areas and further details.
Eligibility
Canadian academic institutions, biotech companies, and research organizations are eligible to apply. Collaborative projects that involve partnerships between academia and industry are also encouraged. CQDM welcomes multidisciplinary teams that can bring diverse expertise to the table.
How to Apply
The submission deadline is April 28, 2025. Please submit the attached submission form (MS Word format) to appliquez-apply@cqdm.org. Detailed guidelines and instructions for proposal submission and the selection form are available on the CQDM website.
Attachment(s)
| Attachment | Size |
|---|---|
 Two_pager___CQDM_RNA_EN.pdf | 203.85 KB |
 Submission_Form_CQDM_RNA.docx | 51.75 KB |